AMD
Heavy Smoking, High BMI Associated With Earlier Onset nAMD
Study also finds intraretinal fluid results in a fast-progressing disease, and these patients tend to be older at the time of diagnosis and remain on treatment for a shorter time.
04/15/2024
Similarities and Differences Between Pachychoroid GA and Conventional GA Identified
Understanding these features may help disease diagnosis in Asian populations. Patients with the former subtype were significantly younger, predominantly male and had a slower progression rate.
04/12/2024
Study Finds Imaging Biomarkers Associated with GA Growth Rate
Progression is positively associated with non-exudative subretinal fluid and hyperreflective material as well as iRORA. It’s negatively associated with retinal pseudocysts and subfoveal choroid thickness.
04/01/2024
Macular Pigment Density May Help Identify Intermediate AMD
Objective perimetry also showed merit in characterizing this stage of the disease.
03/20/2024
Pachydrusen in AMD Eyes Raises Risk of MNV but Not GA
This is especially the case when macular pigmentary changes are also present, study finds.
03/20/2024
OCT Study Finds Outer Retinal Hallmarks of Intermediate AMD
Splitting of the RPE/basal lamina/Bruch’s membrane region, reticular pseudodrusen and subretinal drusen deposits are were prognostic.
03/14/2024
Exudative Biomarkers in Wet AMD Have Distinct Features, Subtype Associations
Subretinal fluid was more predominant in MNV1 while intraretinal fluid presented more often in MNV3.
03/06/2024
En face OCT Measurements Show Vessel-specific Changes in AMD
This approach could provide a more comprehensive understanding of disease-related changes and potentially aid in establishing appropriate care for patients.
03/04/2024
Faricimab Shows Positive Two-year Results Using Treat & Extend Regimen
About 60% of AMD patients maintained vision gains while pushing the dosing interval to 16 weeks.
02/20/2024
Thin Double Layer Sign in the Fovea on OCT Predicts GA
Structural imaging shows the presence of biomarkers associated with the development of foveal atrophy at two years.
02/14/2024
Upcoming Events
May 2, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Kamran Riaz, MD, and Melissa Barnett, OD
Webinar: 7:00pm ET
Sponsored by Bausch + Lomb
May 17-19, 2024
June 4, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Karl G. Stonecipher, MD, and Jessica Steen, OD
Webinar: 8:00pm ET
Sponsored by Bausch + Lomb
